Business Description
Clene Inc. is a Salt Lake City-based pharmaceutical company developing a range of treatments built around its proprietary nanoparticle technology. Its primary focus is CNM-Au8, a gold nanoparticle compound that has been tested across multiple clinical trials targeting neurological conditions such as ALS, Multiple Sclerosis, and Parkinson's Disease. The company is also working on silver and zinc-based compounds aimed at fighting infections and supporting wound recovery. Alongside its drug development work, Clene sells a small portfolio of dietary supplements containing low concentrations of gold, silver, and zinc.
